Assessment of the effect of interval from presentation to surgery on outcome in patients with peri-ampullary malignancy

被引:7
作者
Amr, Bassem [1 ,2 ,3 ]
Shahtahmassebi, Golnaz [4 ]
Briggs, Christopher D. [1 ]
Bowles, Matthew J. [1 ]
Aroori, Somaiah [1 ]
Stell, David A. [1 ,2 ,3 ]
机构
[1] Derriford Hosp, Peninsula HPB Unit, Level 7,Derriford Rd, Plymouth PL6 8DH, Devon, England
[2] Univ Plymouth, Peninsula Sch Med, Plymouth PL6 8BU, Devon, England
[3] Univ Plymouth, Peninsula Sch Dent, Plymouth PL6 8BU, Devon, England
[4] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG1 4BU, England
关键词
RESECTED PERIAMPULLARY ADENOCARCINOMAS; PANCREATIC-CANCER; SINGLE; SURVIVAL;
D O I
10.1016/j.hpb.2015.10.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Delay between diagnosis of peri-ampullary cancer (PC) and surgery may allow tumour progression and affect outcome. The aim of this study was to explore associations of interval to surgery (IS) with pathological outcomes and survival in patients with PC. Method: A database review of all patients undergoing surgery-between 2006 and 2014 was undertaken. IS was measured from diagnosis by. imaging. Potential association between IS and survival was measured using Cox regression analysis, and between IS and pathological outcome with multivariate logistic analysis. Results: 388 patients underwent surgery. The median IS was 49 days (1-551 days), and was not associated with any of the evaluated outcomes in patients with pancreatic (149) or distal bile duct (46) cancer. For patients with ampullary cancer (71) longer IS was associated with improved survival, with median survival of 27.5 months for patients waiting <= median IS (35) and 38.3 months for patients waiting > median IS (36) for surgery (p = 0.041). A higher rate of margin positivity (31.4%) was also noted among patients who waited less than the median IS compared to those waiting longer than this interval (11.4%) (p = 0.032). Conclusion: For patients with ampullary cancer there is a paradoxical improvement in outcome among. those with a longer IS, which may be explained by progression to inoperability of more aggressive lesions.
引用
收藏
页码:354 / 359
页数:6
相关论文
共 26 条
[1]   Treatment of pancreatic cancer: Challenge of the facts [J].
Beger, HG ;
Rau, B ;
Gansauge, F ;
Poch, B ;
Link, KH .
WORLD JOURNAL OF SURGERY, 2003, 27 (10) :1075-1084
[2]   POTENTIALLY RESECTABLE PANCREATIC ADENOCARCINOMA - SPIRAL CT ASSESSMENT WITH SURGICAL AND PATHOLOGICAL CORRELATION [J].
BLUEMKE, DA ;
CAMERON, JL ;
HRUBAN, RH ;
PITT, HA ;
SIEGELMAN, SS ;
SOYER, P ;
FISHMAN, EK .
RADIOLOGY, 1995, 197 (02) :381-385
[3]   Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival [J].
Bourgade, Vincent ;
Drouin, Sarah J. ;
Yates, David R. ;
Parra, Jerome ;
Bitker, Marc-Olivier ;
Cussenot, Olivier ;
Roupret, Morgan .
WORLD JOURNAL OF UROLOGY, 2014, 32 (02) :475-479
[4]  
Chauhan A, 2010, GASTROINTESTINAL S1, pS28
[5]   Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas [J].
Chen, Shih-Chin ;
Shyr, Yi-Ming ;
Wang, Shin-E. .
HPB, 2013, 15 (12) :951-957
[6]   Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors [J].
Cleary, SP ;
Gryfe, R ;
Guindi, M ;
Greig, P ;
Smith, L ;
Mackenzie, R ;
Strasberg, S ;
Hanna, S ;
Taylor, B ;
Langer, B ;
Gallinger, S .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (05) :722-731
[7]   Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution [J].
DeOliveira, Michelle L. ;
Cunningham, Steven C. ;
Cameron, John L. ;
Kamangar, Farin ;
Winter, Jordan M. ;
Lillemoe, Keith D. ;
Choti, Michael C. ;
Yeo, Charles J. ;
Schulick, Richard D. .
ANNALS OF SURGERY, 2007, 245 (05) :755-762
[8]  
*DEP HLTH, 2000, REF GUID SUSP CANC
[9]   Pancreatic cancer: Clinical presentation, pitfalls and early clues [J].
DiMagno, EP .
ANNALS OF ONCOLOGY, 1999, 10 :140-142
[10]  
Duval JV, 2000, ARCH PATHOL LAB MED, V124, P1196